These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7740987)

  • 1. The immune response of small children by antibodies of different classes to respiratory syncytial virus (RSV) proteins.
    Wilczyński J; Lukasik B; Torbicka E; Tranda I; Brzozowska-Binda A
    Acta Microbiol Pol; 1994; 43(3-4):369-79. PubMed ID: 7740987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus (RSV) antibodies in different immunoglobulin classes in small children.
    Wilczyński J; Lukasik B; Torbicka E; Tranda I; Brzozowska-Binda A
    Acta Microbiol Pol; 1994; 43(3-4):359-68. PubMed ID: 7740986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplacental transfer of antibodies to some respiratory viruses.
    Wilczyński J; Lukasik B
    Acta Microbiol Pol; 1994; 43(3-4):347-58. PubMed ID: 7740985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection.
    Cane PA; Thomas HM; Simpson AF; Evans JE; Hart CA; Pringle CR
    J Med Virol; 1996 Mar; 48(3):253-61. PubMed ID: 8801286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus infection in hospitalized patients and healthy children in El Salvador.
    Colocho Zelaya EA; Pettersson CA; Forsgren M; Orvell C; Strannegard O
    Am J Trop Med Hyg; 1994 Nov; 51(5):577-84. PubMed ID: 7985749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus.
    Fisher RG; Crowe JE; Johnson TR; Tang YW; Graham BS
    J Infect Dis; 1999 Oct; 180(4):1324-7. PubMed ID: 10479165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.
    Palomo C; Cane PA; Melero JA
    J Med Virol; 2000 Apr; 60(4):468-74. PubMed ID: 10686032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of IgA and IgG but not IgE antibody to respiratory syncytial virus in nasal washes and sera from infants with wheezing.
    De Alarcon A; Walsh EE; Carper HT; La Russa JB; Evans BA; Rakes GP; Platts-Mills TA; Heymann PW
    J Pediatr; 2001 Mar; 138(3):311-7. PubMed ID: 11241035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
    Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
    J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.
    Harcourt JL; Karron RA; Tripp RA
    J Infect Dis; 2004 Dec; 190(11):1936-40. PubMed ID: 15529257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The humoral immune response of children and infants to an RSV infection: its maturation and association with illness.
    Forster J; Streckert HJ; Werchau H
    Klin Padiatr; 1995; 207(6):313-6. PubMed ID: 8569131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.
    Roca A; Abacassamo F; Loscertales MP; Quintó L; Gómez-Olivé X; Fenwick F; Saiz JC; Toms G; Alonso PL
    J Med Virol; 2002 Aug; 67(4):616-23. PubMed ID: 12116014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.
    Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA
    J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus].
    Zeng RH; Gong W; Fang XP; Zhang ZY; Mei XG
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):534-9. PubMed ID: 16176088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection.
    Piedra PA; Glezen WP; Kasel JA; Welliver RC; Jewel AM; Rayford Y; Hogerman DA; Hildreth SW; Paradiso PR
    Vaccine; 1995 Aug; 13(12):1095-101. PubMed ID: 7491817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge.
    Fischer JE; Johnson TR; Peebles RS; Graham BS
    J Infect Dis; 1999 Sep; 180(3):714-9. PubMed ID: 10438359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of complement in neutralization of respiratory syncytial virus.
    Yoder SM; Zhu Y; Ikizler MR; Wright PF
    J Med Virol; 2004 Apr; 72(4):688-94. PubMed ID: 14981775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection.
    Yamazaki H; Tsutsumi H; Matsuda K; Nagai K; Ogra PL; Chiba S
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():2115-9. PubMed ID: 8046418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.